Evidence map›Paper›PMID 30923437›Full record

ArticlePolymers for advanced technologies2018

Bioactive polymeric formulations for wound healing.

Ahmed A Nada, Michael R Arul, Daisy M Ramos, Zuzana Kroneková, Jaroslav Mosnáček, Swetha Rudraiah, Sangamesh G Kumbar

Open access · greenAbstract read
In one paragraph

Article in Polymers for advanced technologies, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. The GenusFrontiers in pharmacology · 2022
    Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Ahmed A NadaPretreatment & Finishing of Cellulose Based Textiles Dept., National Research Centre, Dokki, Giza, Egypt.
Michael R ArulDepartment of Orthopaedic Surgery, University of Connecticut Health, Farmington, CT, USA.
Daisy M RamosDepartment of Orthopaedic Surgery, University of Connecticut Health, Farmington, CT, USA.
Zuzana KronekováPolymer Institute of the Slovak Academy of Sciences, Dúbravská cesta 9, 84541 Bratislava, Slovakia.
Jaroslav MosnáčekPolymer Institute of the Slovak Academy of Sciences, Dúbravská cesta 9, 84541 Bratislava, Slovakia.ORCID 0000-0001-9160-590X
Swetha RudraiahDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Saint Joseph, Hartford, CT, USA.
Sangamesh G KumbarDepartment of Orthopaedic Surgery, University of Connecticut Health, Farmington, CT, USA.ORCID 0000-0001-7672-4783
Slovak Academy of Sciences · SKUConn Health · USUniversity of Connecticut · USUniversity of Saint Joseph · US

Funding

Biodegradable Matrices for Bone HealingR01EB020640 · NIBIB · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI KUMBAR, SANGAMESH GURAPPA, YU, XIAOJUN · 2017 to 2020
$1.6M
NIBIB NIH HHS R01 EB020640
6 · The paper itself

Abstract

Ricinoleic acid (RA) has potential to promote wound healing because of its analgesic and anti-inflammatory properties. This study investigates the synthesis and characterization of RA liposomes infused in a hydrogel for topical application. Lecithin liposomes containing RA were prepared and incorporated into a chitosan solution and were subsequently cross-linked with dialdehyde β-cyclodextrin (Di-β-CD). Chitosan/Di-β-CD concentrations and reaction temperatures were varied to alter gelation time, water content, and mechanical properties of the hydrogel in an effort to obtain a wide range of RA release profiles. Hydrogel cross-linking was confirmed by spectroscopy, and liposome and carrier hydrogel morphology via microscopy. Chitosan, Di-β-CD, and liposome concentrations within the formulation affected the extent of matrix swelling, mechanical strength, and pore and overall morphology. Higher cross-linking density of the hydrogel led to lower water uptake and slower release rate of RA. Optimized formulations resulted in a burst release of RA followed by a steady release pattern accounting for 80% of the encapsulated RA over a period of 48 hours. However, RA concentrations above 0.1 mg/mL were found to be cytotoxic to fibroblast cultures in vitro because of the oily nature of RA. These formulations promoted wound healing when used to treat full thickness skin wounds (2 cm

Indexed as

chitosan hydrogelliposomesricinoleic acidtopical applicationwound healing

Identifiers

PMID30923437
PMCPMC6435308
OpenAlexW2794577335

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.